- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Naturally Splendid Enters Into License Agreement For Omega Tech
Naturally Splendid (TSXV:NSP) announced today that it has now procured outright ownership of all the omega technologies from Full Spectrum Laboratories (FSL), including HempOmega and H2Omega. The original licensing agreement with FSL granted Naturally Splendid exclusive rights to the omega technologies, with minimum royalty payments to FSL of $1,600,000 CDN annually over ten years beginning in 2017.
Naturally Splendid (TSXV:NSP) announced today that it has now procured outright ownership of all the omega technologies from Full Spectrum Laboratories (FSL), including HempOmega and H2Omega. The original licensing agreement with FSL granted Naturally Splendid exclusive rights to the omega technologies, with minimum royalty payments to FSL of $1,600,000 CDN annually over ten years beginning in 2017.
As quoted in the press release:
In consideration of owning a 100% interest in the omega technologies including HempOmega(R) and H2Omega(TM) and the removal of the Minimum Royalty, Naturally Splendid will extinguish its non-exclusive license of FSL’s bioreactor technology and change its exclusive license on certain analytical testing Standard Operating Procedures (SOPs) to a non-exclusive license.
The transfer of omega technologies to NSE gives the Company full ownership of these technologies and eliminates all minimum royalty payments to FSL, eliminating $16 million in contingent liabilities over the next 10 years.
Naturally Splendid CEO, Craig Goodwin, stated:
Amending our technology license agreement with FSL allows NSE to accomplish a number of important objectives. We believe ownership of the omega technology gives NSE a competitive advantage in the rapidly growing nutritional ingredient industry for human, pet and livestock applications. This allows NSE to create value added products for our customers with improved margins while at the same time eliminating significant royalty obligations to FSL. We have developed our partnership with FSL over the last three years and are continuing to build upon this relationship
Naturally Splendid VP of Operations, Bryan Carson, added:
It is important to point out to our investors and stakeholders that our future business opportunities continue to include the array of technologies under license from FSL, including its patented cannabinoid formulation process. As the regulatory environment continues to evolve, we are strongly of the opinion that we possess very valuable assets that will position NSE for significant future growth, particularly in the development of formulated CBD products.
Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Kit
Outlook Reports
Featured Stocks
Browse Companies
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 2192.51 | +13.07 | |
Silver | 24.57 | +0.13 | |
Copper | 3.99 | -0.02 | |
Oil | 81.44 | -0.18 | |
Heating Oil | 2.60 | -0.02 | |
Natural Gas | 1.71 | -0.08 |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â